relevant BLAs — Regulatory decision
during 2026
Alvotech continues to expect FDA approval for the relevant BLAs during 2026.Source filing
ALVO biotech catalysts & pipeline
ALVOTECH · Data as of 2026-09-08
Upcoming catalysts
Biologics License Applications — PDUFA
late 2026
Alvotech anticipates receiving U.S. approval by late 2026 for four Biologics License Applications from the U.S. Food and Drug Administration, with minimal impact on the topline.Source filing